Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Apr;16(1):20-23.
doi: 10.5005/jp-journals-10078-1351.

One-year Outcomes Following Internal Ligation Suture Removal in 350 mm2 Baerveldt Tube Implant Surgery

Affiliations

One-year Outcomes Following Internal Ligation Suture Removal in 350 mm2 Baerveldt Tube Implant Surgery

Francesco Stringa et al. J Curr Glaucoma Pract. 2022 Jan-Apr.

Abstract

Aim: Long-term data of the postoperative management following Baerveldt tube surgery (BVT) is currently limited. This study aims to evaluate the outcome and the safety profile of internal ligation suture removal after BVT surgery for refractory glaucoma.

Materials and methods: A prospective, consecutive, non-comparative case series of patients previously undergoing BVT 350 mm2 surgery with 0.4 mg/mL mitomycin C (MMC), 3/0 intraluminal suture (Supramid) insertion, and 10/0 nylon external ligation suture(s). For each patient, data was collected over 12 months after internal ligation suture removal. Follow-up assessments looked at intraocular pressure (IOP), complication rate, and postoperative number of glaucoma medications. Definition of success was adopted as per the World Glaucoma Association recommendations.

Results: Twenty-four patients were included. On average, Supramid was removed at 22 ± 18.2 weeks following BVT surgery. Preoperatively, the mean IOP was 30.9 ± 12.6 mm Hg and the average antiglaucoma medications were 1.95 ± 1.13. At 12 months, the mean IOP was 15.2 ± 5.3 mm Hg and the mean number of glaucoma medications was 1.3 ± 0.2. Qualified success with IOP ≤ 21 mm Hg and IOP ≤ 15 mm Hg was achieved in 62.5% and 33.3%, respectively. Only two patients developed hypotony following Supramid removal; both resolved spontaneously within 1 month.

Conclusion: Our results show a good IOP reduction and safety profile at 1 year from internal ligation suture removal following BVT. A drop in IOP of approximately 50% from the preoperative IOP can be expected.

How to cite this article: Stringa F, Chen R, Agrawal P. One-year Outcomes Following Internal Ligation Suture Removal in 350 mm2 Baerveldt Tube Implant Surgery. J Curr Glaucoma Pract 2022;16(1):20-23.

Keywords: Baerveldt implant; Glaucoma drainage devices; Glaucoma surgery.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Fig. 1
Fig. 1
Mean IOP (mm Hg) over time with 95% confidence intervals. IOP, intraocular pressure
Figs 2A and B
Figs 2A and B
Correlations (Pearson's r test) between: (A) number of weeks from Baerveldt implant to suture stent removal and percentage of IOP reduction at 52 weeks; (B) Preoperative IOP (i.e., before suture stent removal) and percentage of IOP reduction at 52 weeks. IOP, intraocular pressure

References

    1. Desai MA, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging. 2011;42(3):202–208. doi: 10.3928/15428877-20110224-04. - DOI - PubMed
    1. Gedde SJ, Chen PP, Heuer DK, et al. The primary tube versus trabeculectomy study: methodology of a multicenter randomized clinical trial comparing tube shunt surgery and trabeculectomy with mitomycin C. Ophthalmology. 2018;125(5):774–781. doi: 10.1016/j.ophtha.2017.10.037. - DOI - PMC - PubMed
    1. Lloyd MA, Baerveldt G, Heuer DK, et al. Initial clinical experience with the Baerveldt implant in complicated glaucomas. Ophthalmology. 1994;101(4):640–650. doi: 10.1016/s0161-6420(94)31283-8. - DOI - PubMed
    1. Sherwood MB, Smith MF. Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology. 1993;100(1):85–90. doi: 10.1016/s0161-6420(93)31688-x. - DOI - PubMed
    1. Shaarawy TM, Grehn F, Sherwood MB. The Hague: Kugler Publications; 2009. Guidelines on design and reporting of glaucoma surgical trials.

LinkOut - more resources